Development and validation of an [<sup>18</sup>F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapy.

Takahashi, Noriyoshi; Tanaka, Shohei; Umezawa, Rei; Takanami, Kentaro; Takeda, Kazuya; Yamamoto, Takaya; Suzuki, Yu; Katsuta, Yoshiyuki; Kadoya, Noriyuki; Jingu, Keiichi

Development and validation of an [¹⁸F]FDG-PET/CT radiomic model for predicting progression-free survival for patients with stage II - III thoracic esophageal squamous cell carcinoma who are treated with definitive chemoradiotherapy.

Takahashi, Noriyoshi; Tanaka, Shohei; Umezawa, Rei; Takanami, Kentaro; Takeda, Kazuya; Yamamoto, Takaya; Suzuki, Yu; Katsuta, Yoshiyuki; Kadoya, Noriyuki; Jingu, Keiichi.

Afiliação

Takahashi N; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Tanaka S; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Umezawa R; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Takanami K; Department of Radiology, Tohoku University Graduate School of Medicine.
Takeda K; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Yamamoto T; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Suzuki Y; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Katsuta Y; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Kadoya N; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.
Jingu K; Department of Radiation Oncology, Tohoku University Graduate School of Medicine.

Acta Oncol ; 62(2): 159-165, 2023 Feb.

Article em En | MEDLINE | ID: mdl-36794365

Assuntos

Neoplasias Esofágicas; Carcinoma de Células Escamosas do Esôfago; Humanos; Tomografia por Emissão de Pósitrons combinada à Tomografia Computadorizada/métodos; Neoplasias Esofágicas/diagnóstico por imagem; Neoplasias Esofágicas/terapia; Fluordesoxiglucose F18; Intervalo Livre de Progressão; Prognóstico; Quimiorradioterapia

Palavras-chave

LASSO cox regression model; PET; esophageal cancer; radiation therapy; radiomics

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Esofágicas / Carcinoma de Células Escamosas do Esôfago Tipo de estudo: Clinical_trials / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Acta Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google